The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism - PubMed (original) (raw)
Review
The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism
Michael Stumvoll et al. Diabetes. 2002 Aug.
Abstract
Peroxisome proliferator-activated receptor (PPAR)-gamma is a transcription factor with a key role in adipocyte differentiation. The Ala allele of the common Pro12Ala polymorphism in the isoform PPAR-gamma2 is associated with reduced risk for type 2 diabetes. The effect on the individual is weak, but because of a prevalence of >75% of the high-risk Pro allele, the population-attributable risk is enormous. The in vivo effects of the polymorphism are secondary to alterations in adipose tissue, where PPAR-gamma2 is predominantly expressed. Moderate reduction in transcriptional activity of PPAR-gamma as a result of the polymorphism modulates production and release of adipose-derived factors. Both decreased release of insulin-desensitizing free fatty acids, tumor necrosis factor-alpha, and resistin and increased release of the insulin-sensitizing hormone adiponectin result in secondary improvement of insulin sensitivity of glucose uptake and suppression of glucose production. The population effect of this polymorphism may be modulated by environmental or genetic factors such as obesity, ethnicity, ratio of unsaturated to saturated fatty acids, and genetic background. Once diabetes has developed, the protective effect of the Ala allele may be lost, since increased vascular complications and more pronounced beta-cell dysfunction have been reported. These observations, however, are currently unexplained. In conclusion, the Pro12Ala polymorphism in PPAR-gamma2 represents the first genetic variant with a broad impact on the risk of common type 2 diabetes. The precise understanding of its mechanism may lead to novel diagnostic, preventive, and therapeutic approaches for improving the management of type 2 diabetes.
Similar articles
- Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.
Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O. Ek J, et al. Diabetologia. 2001 Sep;44(9):1170-6. doi: 10.1007/s001250100629. Diabetologia. 2001. PMID: 11596673 - [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z. Fu M, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002. PMID: 12048686 Chinese. - The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
Tönjes A, Stumvoll M. Tönjes A, et al. Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):410-4. doi: 10.1097/MCO.0b013e3281e389d9. Curr Opin Clin Nutr Metab Care. 2007. PMID: 17563457 Review. - The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.
Celi FS, Shuldiner AR. Celi FS, et al. Curr Diab Rep. 2002 Apr;2(2):179-85. doi: 10.1007/s11892-002-0078-2. Curr Diab Rep. 2002. PMID: 12643137 Review.
Cited by
- Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family Study.
Ruchat SM, Rankinen T, Weisnagel SJ, Rice T, Rao DC, Bergman RN, Bouchard C, Pérusse L. Ruchat SM, et al. Diabetologia. 2010 Apr;53(4):679-89. doi: 10.1007/s00125-009-1630-2. Epub 2009 Dec 31. Diabetologia. 2010. PMID: 20043145 Free PMC article. - Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes.
Weyrich P, Stefan N, Häring HU, Laakso M, Fritsche A. Weyrich P, et al. J Mol Med (Berl). 2007 Feb;85(2):107-17. doi: 10.1007/s00109-006-0134-5. Epub 2006 Dec 13. J Mol Med (Berl). 2007. PMID: 17165091 Review. - Three novel SNPs in the coding region of PPARγ gene and their associations with meat quality traits in cattle.
Fan YY, Zan LS, Fu CZ, Tian WQ, Wang HB, Liu YY, Xin YP. Fan YY, et al. Mol Biol Rep. 2011 Jan;38(1):131-7. doi: 10.1007/s11033-010-0086-2. Epub 2010 Mar 21. Mol Biol Rep. 2011. PMID: 20306301 - Role of TCF7L2 and PPARG2 Gene Polymorphisms in Renal and Cardiovascular Complications among Patients with Type 2 Diabetes: A Cohort Study.
Satirapoj B, Tasanavipas P, Supasyndh O. Satirapoj B, et al. Kidney Dis (Basel). 2019 Oct;5(4):220-227. doi: 10.1159/000497100. Epub 2019 Mar 6. Kidney Dis (Basel). 2019. PMID: 31768379 Free PMC article. - Candidate Genes of Regulation of Skeletal Muscle Energy Metabolism in Athletes.
Balberova OV, Bykov EV, Medvedev GV, Zhogina MA, Petrov KV, Petrova MM, Al-Zamil M, Trefilova VV, Goncharova PS, Shnayder NA. Balberova OV, et al. Genes (Basel). 2021 Oct 23;12(11):1682. doi: 10.3390/genes12111682. Genes (Basel). 2021. PMID: 34828287 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases